MF
Martin Fan Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
42%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
87.5%
Neutral
6.3%
Negative
6.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Reiterated
| $45 |
35%
downside
| 3 | +69% |
0
%
| 13 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $75 |
26%
upside
| 5 | +28% |
0
%
| 12 Mar ‘26 3 months ago |
|
|
|
Outperform
Reiterated
| $38 |
342%
upside
| 2 | -18% |
0
%
| 10 Mar ‘26 3 months ago |
|
|
|
Outperform
Initiated
| $15 |
308%
upside
| 1 | +5% |
0
%
| 9 Feb ‘26 4 months ago |
|
|
|
Outperform
Reiterated
| $45 |
141%
upside
| 3 | +72% |
0
%
| 22 Dec ‘25 5 months ago |
|
|
|
Neutral
Assumed
| $9 |
36%
downside
| 1 | – |
–
| 25 Nov ‘25 6 months ago |
|
|
|
Underperform
Assumed
| $2 |
64%
downside
| 1 | +9.3% |
0
%
| 25 Nov ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $6 |
111%
upside
| 2 | +3.5% |
0
%
| 7 Nov ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $23 |
151%
upside
| 2 | +48% |
0
%
| 17 Oct ‘25 8 months ago |
|